CA2302411C - Procede ameliore destine a empecher la formation de cristaux dans un dispositif d'administration transdermique de scopolamine - Google Patents

Procede ameliore destine a empecher la formation de cristaux dans un dispositif d'administration transdermique de scopolamine Download PDF

Info

Publication number
CA2302411C
CA2302411C CA002302411A CA2302411A CA2302411C CA 2302411 C CA2302411 C CA 2302411C CA 002302411 A CA002302411 A CA 002302411A CA 2302411 A CA2302411 A CA 2302411A CA 2302411 C CA2302411 C CA 2302411C
Authority
CA
Canada
Prior art keywords
scopolamine
scopolamine base
annealed
base
annealing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002302411A
Other languages
English (en)
Other versions
CA2302411A1 (fr
Inventor
Richard L. Braun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority claimed from PCT/US1997/015422 external-priority patent/WO1999011248A1/fr
Publication of CA2302411A1 publication Critical patent/CA2302411A1/fr
Application granted granted Critical
Publication of CA2302411C publication Critical patent/CA2302411C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne un dispositif d'administration transdermique, comprenant une base scopolamine et sensiblement exempt d'hydrates cristallins, ainsi qu'un procédé permettant de fabriquer ledit dispositif.
CA002302411A 1997-09-02 1997-09-02 Procede ameliore destine a empecher la formation de cristaux dans un dispositif d'administration transdermique de scopolamine Expired - Lifetime CA2302411C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/015422 WO1999011248A1 (fr) 1995-04-21 1997-09-02 Procede ameliore destine a empecher la formation de cristaux dans un dispositif d'administration transdermique de scopolamine

Publications (2)

Publication Number Publication Date
CA2302411A1 CA2302411A1 (fr) 1999-03-11
CA2302411C true CA2302411C (fr) 2007-01-30

Family

ID=22261542

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002302411A Expired - Lifetime CA2302411C (fr) 1997-09-02 1997-09-02 Procede ameliore destine a empecher la formation de cristaux dans un dispositif d'administration transdermique de scopolamine

Country Status (2)

Country Link
JP (1) JP2001514213A (fr)
CA (1) CA2302411C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009052972A1 (de) * 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
DE102011090178A1 (de) * 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation

Also Published As

Publication number Publication date
CA2302411A1 (fr) 1999-03-11
JP2001514213A (ja) 2001-09-11

Similar Documents

Publication Publication Date Title
EP1009391A1 (fr) Procede ameliore destine a empecher la formation de cristaux dans un dispositif d'administration transdermique de scopolamine
US4262003A (en) Method and therapeutic system for administering scopolamine transdermally
US4031894A (en) Bandage for transdermally administering scopolamine to prevent nausea
US5626866A (en) Drug-containing adhesive composite transdermal delivery device
US4201211A (en) Therapeutic system for administering clonidine transdermally
EP0708627B1 (fr) Procede et dispositif therapeutique d'administration de substitut de la nicotine par voie transcutanee ou buccale
EP0400078B1 (fr) Dispositif de distribution transcutanee de medicament implante
HU203842B (en) Method for producing single-plane therapy system
MXPA96003667A (en) Composed transdermal supply device adhesive containing dr
EP1137406B1 (fr) Timbre transdermique pour administrer des medicaments liquides volatiles
CA2550704C (fr) Dispositif d'administration transdermique de nicotine
HU204701B (en) Trnasdermal system for transdermal administration of nicotine and process for producing same
MX2012005511A (es) Metodo para prevenir la cristalizacion de sustancias farmaceuticas en una pelicula de polimero.
EP0656771A1 (fr) Dispositif d'apport medicamenteux percutane depose par empreinte
JPH09503756A (ja) 溶媒なしに製造できる揮発性活性物質を含有するプラスター
JPH05255076A (ja) 超音波シールされたドラッグデリバリーシステムの製造方法
HU210845B (en) Process for production of transdermal therapeutic plaster
JP4166276B2 (ja) マトリックスにおける液体の分散液中での結晶形成を防止するための改良された方法
CA2861782A1 (fr) Systeme de traitement transdermique presentant une tendance reduite a la cristallisation spontanee
JP2004529890A (ja) 活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系
NZ207796A (en) Adhesive layered product for controlled release of active ingredients to skin
CA2302411C (fr) Procede ameliore destine a empecher la formation de cristaux dans un dispositif d'administration transdermique de scopolamine
JP2020518553A5 (fr)
JPH07106978B2 (ja) 複合貼付製剤
IL134418A (en) A medical system containing scopolamine for administration through the skin

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170905